INTRODUCTION
Leprosy is one of the oldest recorded diseases to mankind prevalent even
in biblical texts. In recent times multi-drug therapy(MDT) usage has
eliminated this disease as a public health problem from the western
world but the disease is still endemic to low resource settings in
Africa, Asia and South American region.2 The
disease is due to infection of Mycobacterium leprae producing
chronic infection majorly but not limited to skin,nerves and
reticuloendothelial system.3,4 The disease can
however affect upper respiratory tract, bones, joints, eyes, testes and
adrenal glands.4 Clinical spectrum of leprosy
ranges from “paucibacillary” tuberculoid leprosy to “multibacillary”
lepromatous leprosy depending on the immune response of the host
body.5,6 The common clinical findings are hypo
pigmented or erythematous patches which has partial or complete loss of
sensation.4